Complete Blood Counts and Research Parameters in the Detection of Myelodysplastic Syndromes.
Eloísa UrrechagaMónica FernándezUrko Aguirre LarracoecheaPublished in: Diagnostics (Basel, Switzerland) (2024)
MDS are common malignant disorders with a poor prognosis, and early diagnosis is warranted for optimal benefit from treatment. RUO gain insights to detect dysplasia of MDS and could be used in the differential diagnosis of MDS from cytopenias of other etiologies.